NCT03067428已完成不适用
Effects of Fructose Restriction on Liver Steatosis
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 44
- 试验地点
- 2
- 主要终点
- Change in intrahepatic triglyceride content
研究概览
简要总结
Nonalcoholic fatty liver disease (NAFLD) is an emerging health problem as it can lead to end stage liver failure and cardiovascular complications. Diet play an important role in the development of NAFLD. Many studies have addressed the effects of added fructose on NAFLD. To date, little attention has been paid to the effects of a diet devoid of fructose. Therefore, the investigators aim to study the effects of fructose restriction on hepatic fat accumulation and vascular function using a double-blind randomized placebo-controlled design.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Basic Science
- 盲法
- Triple (Participant, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Age ≥ 18 years
- •Body mass index ≥ 28 kg/m2
- •Fatty liver index ≥ 60
- •Fructose intake ≥45 grams/day
排除标准
- •Medical history of liver disease
- •(History of) excessive alcohol consumption (defined as > 2 units/day for women, and > 3 units/day for men)
- •Major change in weight and/or physical activity prior to the study
- •Use of glucose lowering drugs
- •Recent illness
- •Pregnancy and/or lactation
- •Contraindications for magnetic resonance imaging
- •Inability to give informed consent
- •Protocol change (implemented on July 18, 2018): in order to increase the inclusion of study participants, subjects with an average daily fructose intake < 45 gram/day will also be eligible for participation. In subjects who have an average daily fructose intake < 45 gram/day, supplementation of either fructose or glucose (see 'Arms and Interventions') will be increased to 45 gram/day.
结局指标
主要结局
Change in intrahepatic triglyceride content
时间窗: 6 weeks
Assessed by magnetic resonance spectroscopy
次要结局
- Change in endothelial function (RHI)(6 weeks)
- Change in endothelial function (panel of endothelial dysfunction biomarkers)(6 weeks)
- Change in arterial stiffness (PWV)(6 weeks)
- Change in endothelial function (flowmotion and skin heating response)(6 weeks)
- Change in glucose metabolism(6 weeks)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
2 期
Ketohexokinase Inhibition in NAFLDNAFLDNCT05463575Maastricht University Medical Center15
已完成
不适用
Diet Impact on Hepatic Transcriptomics and Lipidomics in Pre-diabetesPre-diabetesNCT05965973Laval University6
已完成
不适用
Impact of Fructose Consumption on Intestinal Permeability in Non-alcoholic Fatty Liver Disease (NAFLD) - a Pilot Study.Non-alcoholic Fatty Liver DiseaseNon-alcoholic SteatohepatitisNCT01696487Medical University of Vienna10
尚未招募
不适用
Influence of Diabetic Control on the Degree of Liver Fibrosis Assessed by Non-invasive Scores in Patients Followed in DiabetologyDiabete Type 2NCT05605821Fondation Hôpital Saint-Joseph520
Unknown
不适用
Unravelling Mechanisms of Fructose vs Glucose Consumption in the Pathogenesis and Progression of NAFLDNon-alcoholic Fatty Liver DiseaseNon-alcoholic SteatohepatitisNCT02075164Prof. Michael Trauner, MD56